Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted thienopyrimidinones as a mitotic kinesin inhibitor

Substituted thienopyrimidinones as a mitotic kinesin inhibitor

US Patent 7378411 · Granted May 27, 2008

Estimated economic value: $194,601,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of NLRP3 inflammasome2025
Inhibitors of NLRP3 inflammasome2025
N-oxide inhibitors of NLRP3 inflammasome2024
N-oxide inhibitors of NLRP3 inflammasome2023
Inhibitors of NLRP3 inflammasome2023
Inhibitors of NLRP3 inflammasome2023
Combinations and methods comprising a capsid assembly inhibitor2021
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetyla2021
Oxadiazepinone derivatives and methods of treating hepatitis B infections2021
Diazepinone derivatives and their use in the treatment of hepatitis B infections2021
Combination therapy for treatment of HBV infections2020
Derivatives and methods of treating hepatitis B infections2020